Intravenous immunoglobulin treatment in a child with resistant atopic dermatitis (Q35770152)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 February 2012

edit

Language	Label	Description	Also known as
English	Intravenous immunoglobulin treatment in a child with resistant atopic dermatitis	scientific article published on 2 February 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

case report

0 references

title

Intravenous immunoglobulin treatment in a child with resistant atopic dermatitis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

author name string

Hyuck Hoon Kwon

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

Kyu Han Kim

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

publication date

2 February 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

published in

Annals of dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

page(s)

66-69

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 January 2012

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Differences between IGIV products: impact on clinical outcome

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

Clinical practice. Atopic dermatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

Dermatological Uses of High-Dose Intravenous Immunoglobulin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

Eczema and thrombocytopenia in an 8-month-old infant boy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

High dose gammaglobulin treatment for atopic dermatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

12 July 2018

Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

25 September 2018

A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

25 September 2018

Mycophenolate mofetil is effective in the treatment of atopic dermatitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

25 September 2018

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

25 September 2018

High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3283853

retrieved

25 September 2018

Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22363158

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on the use of high-dose intravenous immunoglobulin in dermatology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22363158

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22363158

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab in the treatment of moderate to severe atopic dermatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22363158

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22363158

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.5021/AD.2012.24.1.66

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

PMC publication ID

3283853

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

PubMed publication ID

22363158

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22363158

retrieved

10 August 2017

ResearchGate publication ID

221859442

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35770152&oldid=1868237681"